[Ip-health] Lancet Oncology Comment on new WHO Essential Cancer Drugs

Ellen 't Hoen ellenthoen at medicineslawandpolicy.net
Fri Jul 12 21:43:27 PDT 2019

Dear IP-Health readers,

Yesterday, the Lancet Oncology published a comment we wrote on the addition of 10 (12 if you count the alternatives) cancer medicines to the WHO Model List of Essential Medicines and the need for action at international and national level to ensure these medicines are available and affordable for people with cancer.

You can access the paper here:

Kind regards,

Ellen ‘t Hoen
Ellen ‘t Hoen LLM, PhD | Medicines Law & Policy
E-mail: ellenthoen at medicineslawandpolicy.net
Twitter: @ellenthoen

More information about the Ip-health mailing list